Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

FDMT

4D Molecular Therapeutics, Inc.

CIK 0001650648 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$12.89
↓ 0.13 (-1.00%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Options

Key stats

Market Cap
$641.64M
P/E Ratio
-3.99
EPS
-2.42
Dividend Yield
Not covered
52W Position
89%
Beta
1.32

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.42
P/S
7.27
EV/Revenue
6.45
ROE
-35.6%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 89%
$4.11$14.00

Latest Financials

2025-12-31 FY
Revenue
$85.21M
Net Income
-$140.11M
Total Assets
$566.71M
Free Cash Flow
-$109.62M

Recent news